Evidence map›Paper›PMID 32520909›Full record

Trial reportJournal of acquired immune deficiency syndromes (1999)2020

Impact of Routine Point-of-Care Versus Laboratory Testing for Early Infant Diagnosis of HIV: Results From a Multicountry Stepped-Wedge Cluster-Randomized Controlled Trial.

Emma Sacks, Jennifer Cohn, Bernard Ochuka, Haurovi Mafaune, Addmore Chadambuka, Collins Odhiambo, Rose Masaba, George Githuka, Agnes Mahomva, Angela Mushavi and 3 more

Open access · hybridAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. A Randomized Trial of Point-of-Care Early Infant Human Immunodeficiency Virus (HIV) Diagnosis in Zambia.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective three-arm study.Liver international : official journal of the International Association for the Study of the Liver · 2022
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Emma SacksDepartment of Global Health, George Washington School of Public Health, Washington, DC.
Jennifer CohnElizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Bernard OchukaElizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
Haurovi MafauneElizabeth Glaser Pediatric AIDS Foundation, Harare, Zimbabwe.
Addmore ChadambukaElizabeth Glaser Pediatric AIDS Foundation, Harare, Zimbabwe.
Collins OdhiamboElizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
Rose MasabaElizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
George GithukaMinistry of Health, Nairobi, Kenya; and.
Agnes MahomvaMinistry of Health and Child Care, Harare, Zimbabwe.
Angela MushaviMinistry of Health and Child Care, Harare, Zimbabwe.
Jean-Francois LemaireElizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.
Flavia BianchiElizabeth Glaser Pediatric AIDS Foundation, Washington, DC.
Rhoderick MachekanoElizabeth Glaser Pediatric AIDS Foundation, Washington, DC.
Elizabeth Glaser Pediatric AIDS Foundation · USMinistry of Health and Child Welfare · ZWMinistry of Health · KE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough the World Health Organization recommends HIV-exposed infants receive a 6-week diagnostic test, few receive results by 12 weeks. Point-of-care (POC) early infant diagnosis (EID) may improve timely diagnosis and treatment. This study assesses the impact of routine POC versus laboratory-based EID on return of results by 12 weeks of age.

methodsThis was a cluster-randomized stepped-wedge trial in Kenya and Zimbabwe. In each country, 18 health facilities were randomly selected for inclusion and randomized to timing of POC implementation.

findingsNine thousand five hundred thirty-nine infants received tests: 5115 laboratory-based and 4424 POC. In Kenya and Zimbabwe, respectively, caregivers were 1.29 times [95% confidence interval (CI): 1.27 to 1.30, P < 0.001] and 4.56 times (95% CI: 4.50 to 4.60, P < 0.001) more likely to receive EID results by 12 weeks of age with POC versus laboratory-based EID. POC significantly reduced the time between sample collection and return of results to caregiver by an average of 23.03 days (95% CI: 4.85 to 21.21, P < 0.001) in Kenya and 62.37 days (95% CI: 58.94 to 65.80, P < 0.001) in Zimbabwe. For HIV-infected infants, POC significantly increased the percentage initiated on treatment, from 43.2% to 79.6% in Zimbabwe, and resulted in a nonsignificant increase in Kenya from 91.7% to 100%. The introduction of POC EID also significantly reduced the time to antiretroviral therapy initiation by an average of 17.01 days (95% CI: 9.38 to 24.64, P < 0.001) in Kenya and 56.00 days (95% CI: 25.13 to 153.76, P < 0.001) in Zimbabwe.

conclusionsPOC confers significant advantage on the proportion of caregivers receiving timely EID results, and improves time to results receipt and treatment initiation for infected infants. Where laboratory-based EID systems are unable to deliver results to caregivers rapidly, POC should be implemented as part of an integrated testing system.

Indexed as

Point-of-Care TestingEarly DiagnosisFemaleHIV InfectionsHIV TestingHumansInfantInfant, NewbornKenyaMaleZimbabwe

Identifiers

PMID32520909
PMCPMC7302335
OpenAlexW3033198495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.